Manufacturer record

Macleods Pharmaceuticals Ltd. - Khasra No. 21: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Macleods Pharmaceuticals Ltd. - Khasra No. 21 (Sikkim) were declared Not of Standard Quality between September 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Macleods Pharmaceuticals Ltd. - Khasra No. 21 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2025 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2025
3
Products affected
Other
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2025 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ferrous Ascorbate, Folic Acid and Cyanocobalamin Suspension 18260226AMfg 2026-01 · Exp 2028-12 Identity test negative for Folic Acid & content of Elemental IronOther Lucknow LabState lab Jul 2026
Ferrous Assorbate, Folic Acid and Cyanocobalamin Suspension 18260226AMfg 2026-01 · Exp 2028-12 01. ASSAY OF FOLIC ACID I.P. ?Less than prescribed limit.Assay SFDTL UttarakhandState lab Jul 2026
Clobetasol Propionate Neomycin Sulphate and Miconazole Nitrate Cream 18241408AMfg 2024-07 · Exp 2026-06 SpouriosOther SDTL Raipur ChhattisgarhState lab Sep 2025

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
Deflazacort Tablets 6 mg Defcort 613240334ARDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.